Related Experiment Video

Updated: Aug 9, 2026

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs
07:24

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs

Published on: March 13, 2026

[Non-pharmacological treatment of hypertrophic obstructive cardiomyopathy guided by echocardiography]

Giovanni La Canna1, Matteo Montorfano, Eleonora Ficarra

  • 1Sezione di Ecocardiografia, Divisione di Cardiochirurgia, Istituto Universitario San Raffaele, Milano. lacanna.giovanni@hsr.it

Giornale Italiano Di Cardiologia (2006)
|April 1, 2006
PubMed

Insights

Left ventricular obstruction in hypertrophic obstructive cardiomyopathy requires targeted therapy. Surgical and percutaneous septal ablation offer non-pharmacological options, with echocardiography guiding treatment and monitoring outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Left ventricular obstruction (LVO) significantly impacts symptoms and prognosis in hypertrophic obstructive cardiomyopathy (HCM).
  • Non-pharmacological interventions are crucial for managing symptomatic LVO unresponsive to medical therapy.

Purpose of the Study:

  • To review the role of non-pharmacological treatments for LVO in HCM.
  • To highlight the established efficacy of surgical approaches and the emerging role of percutaneous septal ablation.
  • To emphasize the diagnostic and monitoring utility of Doppler echocardiography in these therapies.

Main Methods:

  • Review of surgical techniques (septal myectomy, mitral valve surgery) for dynamic obstruction.
  • Analysis of percutaneous transluminal septal myocardial ablation as a treatment modality.
  • Discussion of Doppler echocardiography's role in planning and intraprocedural guidance.

Main Results:

  • Surgical interventions are effective in relieving symptoms caused by dynamic obstruction.
  • Percutaneous septal ablation is effective in abolishing obstruction, but long-term prognostic data regarding procedural myocardial damage is limited.
  • Doppler echocardiography is essential for accurate diagnosis, procedural planning, and monitoring of non-pharmacological therapies.

Conclusions:

  • Left ventricular obstruction is a key therapeutic target in hypertrophic obstructive cardiomyopathy.
  • Both surgical and percutaneous approaches offer viable non-pharmacological treatment options.
  • Doppler echocardiography is indispensable for optimizing patient management in hypertrophic obstructive cardiomyopathy requiring intervention.

More Related Videos

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy09:24

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

Published on: October 6, 2022

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...